The Column Group III, LP 13D and 13G filings for Revolution Medicines, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 5:22 pm Sale | 2023-12-31 | 13G | Revolution Medicines, Inc. RVMD | The Column Group III, LP | 46 0.000% | -3,347,153 (-100.00%) | Filing |
| 2023-02-13 4:23 pm Unchanged | 2022-12-31 | 13G | Revolution Medicines, Inc. RVMD | The Column Group III, LP | 3,347,199 3.800% | 0 (Unchanged) | Filing |
| 2022-02-11 4:23 pm Sale | 2021-12-31 | 13G | Revolution Medicines, Inc. RVMD | The Column Group III, LP | 3,347,199 4.500% | -233,007 (-6.51%) | Filing |
| 2021-02-12 6:25 pm Purchase | 2020-12-31 | 13G | Revolution Medicines, Inc. RVMD | The Column Group III, LP | 3,580,206 4.900% | 3,580,206 (New Position) | Filing |